Skip to main content
. 2005 Nov 23;55(9):1064–1071. doi: 10.1007/s00262-005-0092-8

Fig. 1.

Fig. 1

CD4(+)CD25high T cells in PBMCs from patients with gastric and esophageal cancers. The population of CD4(+)CD25high T cells as a percentage of the total CD4(+) cells was evaluated by flow cytometric analysis with triple-color staining. Representative flow cytometric data from gastric (stage III) and esophageal cancer patients (stage III) and healthy donors are shown. Rectangular gates indicate CD4(+)CD25high T cell populations